Press Release|Articles|November 16, 2026 (Updated: November 16, 2026)

The Pan-Mass Challenge Exceeds 2026 Fundraising Goal with Record-Breaking $80 Million Gift Fueling Lifesaving Research at Dana-Farber Cancer Institute

Listen
0:00 / 0:00

Key Takeaways

  • A record $80 million gift increased cumulative philanthropic support for Dana-Farber to more than $1.2 billion, with 100% of rider-raised dollars directed to the institute.
  • The timing is strategically important as federal research funding and grant success rates contract while projected global cancer incidence exceeds 20 million new cases in 2026.
SHOW MORE

The Pan-Mass Challenge donated a record $80 million to Dana-Farber Cancer Institute to support cancer research, treatment, and patient care.

The Pan-Mass Challenge (PMC), a bike-a-thon which has raised more money for charity than any other single athletic fundraising event in the world, today presented a record-breaking $80 million gift to Dana-Farber Cancer Institute, one of the nation's top three cancer hospitals. Presented at a celebratory brunch at Rochambeau in Boston, this gift brings the PMC’s total contribution to Dana-Farber's mission to more than $1.2 billion.

For the 20th consecutive year, 100 percent of every rider-raised dollar goes directly to Dana-Farber. Powered by thousands of riders and volunteers from across the world, every dollar raised helps fuel groundbreaking cancer research, lifesaving treatments, and patient care.

“$80 million isn’t just a number. It represents the next clinical trial, the next breakthrough, the next life saved, and the next patient who gets to ring the bell at the end of treatment,” said Billy Starr, PMC founder and chairman. “Now, more than ever, our riders, volunteers, donors, and corporate partners understood exactly what was at stake. They didn’t just meet the moment, they rode right past it. I’ve never been prouder of this community, and I’ve never been more confident that the cures we ride for are within reach.”

The record-breaking gift arrives at a pivotal moment in the nation. While federal research support and grant approval rates are shrinking, cancer rates continue to climb, with more than 20 million new cancer cases projected worldwide in 2026 alone. The PMC’s sustained giving is one of the most essential forces keeping transformative research at Dana-Farber moving forward.

"We are immensely grateful for the PMC’s longstanding support of Dana-Farber,” said Benjamin L. Ebert, MD, PhD, president and CEO of Dana-Farber Cancer Institute and PMC rider. “This unprecedented gift is an important milestone and will be used to shape the future of cancer care and research at Dana-Farber. I am honored to be one of thousands of committed PMC riders and volunteers who have played a role in making a big impact.”

The PMC is Dana-Farber’s single largest contributor, accounting for 67 percent of revenue for the Jimmy Fund, Dana-Farber's community fundraising arm. But the most significant measure of the PMC’s funding is found in the discoveries that bring new hope to patients and families facing cancer. PMC support helped drive some of Dana-Farber's most significant recent breakthroughs, including the discovery of menin inhibitors, the improvement of multi-cancer early detection, and the development of new types of cell therapies such as CAR-T cell therapy and tumor-infiltrating lymphocyte (TIL) therapy.

The unprecedented gift reflects a full year of riding and fundraising. In addition to the flagship PMC weekend, crucial funding was supported by the PMC’s further spokes in the wheel, including PMC Winter Cycle, an indoor spin event at Fenway Park; PMC Unpaved, a gravel bike ride; and PMC Kids Rides, mini bike-a-thons for children ages 2 to 15.



Related to this article